BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression.

Brain Pathology
Christian KoelscheDavid Capper

Abstract

BRAF V600E mutation and homozygous deletion of CDKN2A (p16) are frequent molecular alterations in pleomorphic xanthoastrocytomas (PXAs). We investigated 49 PXAs for clinical, histological and immunohistochemical characteristics related to BRAF mutation status. BRAF mutation was detected by immunohistochemical assay and DNA sequencing in 38/49 (78%) tumors. All but one PXA located in the temporal lobe harbored a BRAF V600E mutation (23/24; 96%) compared with 10/19 nontemporal PXAs (53%; P = 0.0009). Histological and immunohistochemical analysis demonstrated increased reticulin deposition (76% vs. 27%; P = 0.003) and a more frequent expression of CD34 in BRAF-mutant PXAs (76% vs. 27%; P = 0.003). We further investigated the utility of combined BRAF V600E (VE1) and p16 analysis by immunohistochemistry to distinguish PXAs from relevant histological mimics like giant-cell glioblastoma. Among PXAs, 38/49 (78%) were VE1-positive, and 30/49 (61%) had a loss of p16 expression. The combined features (VE1 positivity/p16 loss) were observed in 25/49 PXAs (51%) but were not observed in giant-cell glioblastoma (VE1 0/28, p16 loss 14/28). We demonstrate that temporal location, reticulin deposition and CD34 expression are associated with BRAF ...Continue Reading

References

Jul 13, 1999·Microscopy Research and Technique·I BlümckeO D Wiestler
Mar 27, 2002·The American Journal of Surgical Pathology·Caterina GianniniScott R VandenBerg
Mar 8, 2003·Acta Neuropathologica·G ReifenbergerI Blümcke
May 1, 2007·Journal of Chemical Neuroanatomy·G F JirikowskiJ D Caldwell
Nov 12, 2009·Brain Pathology·David CapperAndreas von Deimling
Feb 17, 2010·Neuro-oncology·Margaret J DoughertyJaclyn A Biegel
Jul 31, 2012·Journal of Neuro-oncology·Stephanie M PerkinsEric T Shinohara
Aug 15, 2012·Journal of the American Academy of Dermatology·Alexander SkorokhodPeter Helmbold
Oct 3, 2012·The American Journal of Surgical Pathology·Georgina V LongRichard A Scolyer
Oct 26, 2012·Journal of Neuro-oncology·Yao SchmidtDenise Damek
Jan 15, 2013·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Suvendu PurkaitChitra Sarkar
Feb 26, 2013·Acta Neuropathologica·Christian KoelscheDavid Capper
Apr 5, 2013·The American Journal of Surgical Pathology·Bette Kay Kleinschmidt-DeMastersNicholas K Foreman
Apr 16, 2013·Nature Genetics·Jinghui ZhangUNKNOWN St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project
Apr 18, 2013·Oncotarget·Chetan BettegowdaNickolas Papadopoulos
Apr 24, 2013·Acta Neuropathologica·Sonika DahiyaJeffrey R Leonard
Aug 15, 2013·Brain Pathology·Avanita S PrabowoEleonora Aronica
Nov 21, 2013·Acta Neuropathologica Communications·Cristiane M IdaCaterina Giannini

❮ Previous
Next ❯

Citations

Nov 5, 2015·Expert Opinion on Investigational Drugs·Matthias PreusserPeter Birner
Oct 17, 2014·Brain Pathology·Cristiane M IdaCaterina Giannini
Jul 30, 2015·Journal of Neuropathology and Experimental Neurology·Claire FaulknerKathreena Mary Kurian
Oct 27, 2015·Brain Tumor Pathology·Masaya NagaishiAkio Hyodo
Oct 12, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E TabouretD Figarella-Branger
May 6, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Matteo MartinoniMarco Giulioni
May 3, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Carolina BenjaminDonato Pacione
Jan 1, 2015·Nature Reviews. Disease Primers·Michael WellerGuido Reifenberger
May 21, 2015·Der Nervenarzt·D Capper, G Reifenberger
Jun 9, 2015·Seminars in Radiation Oncology·Adriana Olar, Erik P Sulman
Mar 7, 2015·Revue neurologique·S GataullinaC Bulteau
Aug 11, 2016·Diagnostic Pathology·Yue-Feng JiangEn-Hua Wang
Oct 30, 2016·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Ryusuke HataeKoji Iihara
Dec 30, 2016·Nature Reviews. Clinical Oncology·Guido ReifenbergerMichael Weller
Apr 16, 2015·Journal of Child Neurology·Jason T Huse, Marc K Rosenblum
Jul 28, 2018·Brain Pathology·Joanna J PhillipsDavid A Solomon
Oct 1, 2014·Current Opinion in Neurology·Anna Sophie Berghoff, Matthias Preusser
Jul 11, 2019·Acta Neuropathologica Communications·Barry CheaneyMatthew D Wood
Jan 20, 2020·Neuropathology and Applied Neurobiology·E Perez, D Capper
Jan 24, 2016·Journal of Child Neurology·Kim Kramer
Mar 16, 2017·Brain and Behavior·Quentin BretonAudrey Rousseau
Jul 5, 2017·Virchows Archiv : an International Journal of Pathology·Sean P FerrisArie Perry
Feb 11, 2015·Advances in Anatomic Pathology·Sriram Venneti, Jason T Huse
Apr 29, 2016·Journal of Pediatric Hematology/oncology·Andrew J DodgshunMichael J Sullivan
Sep 11, 2019·Journal of Neuro-oncology·Laflamme PhilippeLarouche Valérie
Aug 10, 2017·Journal of Neuropathology and Experimental Neurology·Yvonne SchweizerDavid Capper
Apr 30, 2020·World Neurosurgery·Sang Ho KimChae-Yong Kim
Dec 29, 2020·International Journal of General Medicine·Jing LiuXia Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.